We Know Nail Infections are Difficult to Diagnose & Expensive to Treat
TARGETED TECHNOLOGY. Knowing the genus/species of the causative agent with 99.9% analytical specificity allows for targeted therapy.1
ACCURATE. Correlates highly with gold standard histology with 86% sensitivity, while providing identification of genus/species.1
TIMELY. Rapid results in 24-48 hours mean the right treatment, right away.
COST EFFECTIVE. Quick identification of genus/species supports informed treatment decisions that can more quickly lead to effective outcomes.2.
REQUIRED. Many payors require precise identification of fungal species for preauthorization of anti-fungal Rx.
COVERED. Bako’s onychodystrophy DNA test is covered by Medicare and most insurance plans.